Cat.No. |
Product Name |
Information |
Area |
T4042 |
Talabostat mesylate |
Talabostat mesylate is an orally active, selective inhibitor of dipeptidyl peptidases... |
Cancer |
T6999 |
Teneligliptin hydrobromide |
Teneligliptin is a novel, potent, and long-lasting dipeptidyl peptidase-4 inhibitor; ... |
Others |
T6237 |
Trelagliptin |
Trelagliptin is a highly specific and long-acting DPP-4 inhibitor. |
Cancer |
T6203 |
Saxagliptin |
Saxagliptin is a selective and reversible DPP4 inhibitor with IC50 of 26 nM. |
Cancer |
T6192 |
Alogliptin |
Alogliptin(SYR-322) is a potent, selective inhibitor of DPP-4 with IC50 of <10 nM, ex... |
Cancer |
T2401 |
Alogliptin Benzoate |
Alogliptin Benzoate(SYR 322), an effective and specific DPP-4 inhibitor (IC50<10 nM),... |
Metabolism system |
T2316 |
Omarigliptin |
Omarigliptin has been used in trials studying the treatment of Type 2 Diabetes Mellit... |
Metabolism system |
T2296 |
Trelagliptin succinate |
Trelagliptin(SYR-472) is a long-acting inhibitor of dipeptidyl peptidase-4 (DPP-4), b... |
Metabolism system |
T1581 |
Picolamine |
Picolamine acts as a potential inhibitor of DPP-4. |
Nervous system |
T1502 |
Vildagliptin |
Vildagliptin is a cyanopyrrolidine-based, orally bioavailable inhibitor of dipeptidyl... |
Metabolism system |
T1366 |
3-Pyridylacetic acid hydrochloride |
3-Pyridylacetic acid hydrochloride is an organic compunds |
Other |
T0242 |
Sitagliptin |
Sitagliptin, a new oral hypoglycemic (anti-diabetic drug), is a new dipeptidyl pepti... |
Metabolism system |
T0191 |
Linagliptin |
Linagliptin is a potent, orally bioavailable dihydropurinedione-based inhibitor of di... |
Metabolism system |
T0178 |
Saxagliptin hydrate |
Saxagliptin is a selective and reversible DPP4 inhibitor (IC50: 26 nM; Ki: 1.3 nM). |
Metabolism system |
T0127 |
Glimepiride |
Glimepiride is a long-acting, third-generation sulfonylurea with hypoglycemic activit... |
Metabolism system |